Patients | CRX ILO classification* | Main HRCT findings* | CRX ILO classification†| Main HRCT findings‡ | Si (%) ξ | Al (%) ξ | Progression rate per Year (PRY) |
---|---|---|---|---|---|---|---|
S1 | SS 2/3 q/t | A,B,F | FMP A | A,B,E,D,F | 0.07 | 0.0525 | 0.2727273 |
S2 | PMF B | A,B,E | FMP C | A,B,E | 0.595 | 0.165 | 0.0909091 |
S3 | SS 2/2 r/q | A,B, D | FMP B | A,B,D,E | 1.1325 | 0.3075 | 0.4545455 |
S4 | SS 2/3 r/q | A,B,C | FMP C | A,B,D,E | 1.1025 | 0.3075 | 0.4545455 |
S5 | SS 3/2 r/q | A | SS 3/3 r/q | A,B | 0.05 | 0.0875 | 0.0909091 |
S6 | SS 1/2 q/q | A,B,C | SS 1/2 q/q | A,B | 0.085 | 0.1725 | 0 |
S7 | SS 2/2 q/t | A, B, | SS 2/2 q/t | A, B, | 0.2775 | 0.0675 | 0 |